Dr. Risheen Suresh Reejhsinghani, MD

Dr. Reejhsinghani practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Reejhsinghani's NPI, 1508012154, was assigned on August 14, 2008. Dr. Reejhsinghani graduated from KJ Somaiya Medical College in 2005. Dr. Reejhsinghani holds California license A129653.

Dr. Reejhsinghani's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Reejhsinghani's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Reejhsinghani is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Reejhsinghani to 2 more hospitals and 1 medical group, each named with a free account. Dr. Reejhsinghani's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reejhsinghani practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Reejhsinghani's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Reejhsinghani is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Reejhsinghani's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists aneurysm, atherosclerosis, atrial fibrillation and flutter, cardiac arrhythmia, chronic hypertension, circulation problems, congestive heart failure and coronary artery disease among the conditions Dr. Reejhsinghani treats.

CMS data shows 138 Medicare services from Dr. Reejhsinghani across 3 procedure codes in 2024, for 149 Medicare patients. Medicare paid $9,870 for them.

CMS counts 149 Medicare patients who saw Dr. Reejhsinghani in 2024. The largest group is 75 to 84, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reejhsinghani's median patient age at 57, with 51% women.

In 2024, Dr. Reejhsinghani wrote 1,050 Medicare Part D claims for 146 patients. 90% of them were for generic drugs. CMS names the drug for 890 of them, across 16 drugs with 11 or more claims each, at $98,013 in total drug cost. In 2023, CMS named 1,069 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Reejhsinghani for performance year 2024, reported as part of a group. Dr. Reejhsinghani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reejhsinghani as offering telehealth.

Dmand AI links 8 papers to Dr. Reejhsinghani, published from 2015 to 2023. 2023 was the busiest year, with 3. The most frequent topics are Elective Surgical Procedures and Postoperative Complications. Dr. Reejhsinghani's most frequent co-authors are Neil Manohar Kalwani, MD, Javier Lorenzo, MD and James Christian McAvoy, MD.

CMS Open Payments shows 1 general payment to Dr. Reejhsinghani from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $117.

Dr. Reejhsinghani graduated from KJ Somaiya Medical College in 2005. Dr. Reejhsinghani is a member of ACC.

Dr. Reejhsinghani is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.